Reengineering Chemotherapy for Solid Tumors...Lew Bender, Founder, President & CEO, Intensity Therapeutics
What if chemotherapy could be delivered in a focused way, directly to a tumor, and only where it's needed? Intensity Therapeutics Founder, President, & CEO Lew Bender shares how they're working to change how chemotherapy is delivered to solid tumors, personalized for each patient, with the hopes of reducing the toll it takes on the body.
